EAHAD/LinkedIn
May 21, 2026, 07:23
EAHAD Highlights the Power of Clinical Trials in Haemophilia
EAHAD (European Association for Haemophilia and Allied Disorders) shared a post on LinkedIn:
“This Clinical Trials Day, we recognize the critical role that clinical research plays in driving innovation and improving outcomes for people living with haemophilia.
Within this context, the EAHAD Gene Therapy Trials Database provides a publicly accessible resource that consolidates the latest published gene therapy data, with a particular focus on safety outcomes.
By bringing structured and up-to-date evidence into one place, the platform supports a clearer understanding of ongoing and completed clinical research in the field.
Access the database.”
Stay updated with Hemostasis Today.
-
May 21, 2026, 08:07Follow the WHA Discussion on Bleeding Disorders Live – WFH
-
May 21, 2026, 07:10Chai Phua: 1st Publicly Funded Hemgenix Treatment for Hemophilia B in Canada Marks Historic Gene Therapy Milestone
-
May 21, 2026, 07:10Satyam Arora: Improving Thalassemia Outcomes Through Evidence-Based Practice
-
May 21, 2026, 06:55Hayley Evans: Scaling PBM Quality Improvement Through Automated TXA Tracking
-
May 21, 2026, 06:54Ashkan Shoamanesh: FDA Grants Asundexian A Priority Review for Secondary Stroke Prevention
-
May 21, 2026, 06:49Erwin Loh: Higher-Than-Recommended Physical Activity Levels Linked to Greater Reduction in Heart Attack and Stroke Risk
-
May 21, 2026, 04:54Enrico Ferro: Thank You Niraj Sharma for Covering Our AFib Ablation Stroke Safety Analysis
-
May 21, 2026, 04:38Luca Bonanni: How Mesenchymal Stromal Cells Interact With Coagulation and Innate Immunity
-
May 21, 2026, 04:27Anirban Sen Gupta: Congratulations to Solomon Oshabaheebwa on His PhD Defense in Microfluidic Diagnostics for SCD